Temporary Interruption of Endocrine Therapy for Breast Cancer Safe
THURSDAY, May 4, 2023 (HealthDay News) — Among select women with previous hormone receptor-positive early breast cancer, there is no increase in the short-term risk for breast cancer events with temporary interruption of endocrine therapy to attempt …
Learn MoreFTD-TPI Plus Bevacizumab Increases Survival in Refractory Advanced CRC
THURSDAY, May 4, 2023 (HealthDay News) — Treatment with trifluridine-tipiracil (FTD-TPI) plus bevacizumab yields longer overall survival than FTD-TPI alone among patients with refractory metastatic colorectal cancer, according to a study published in…
Learn MoreExperimental Drug for Alzheimer Disease Slows Decline in Thinking
WEDNESDAY, May 3, 2023 (HealthDay News) — Another experimental drug meant for Alzheimer disease looks so promising that drugmaker Eli Lilly plans to ask the U.S. Food and Drug Administration for full approval by the end of June.Known as donanemab, th…
Learn Moreβ-Blockers Seem Not to Reduce Risks More Than One Year After Heart Attack
WEDNESDAY, May 3, 2023 (HealthDay News) — For patients with myocardial infarction (MI), beta-blocker (βB) treatment beyond one year after MI does not appear to reduce the risk for mortality or further MI, according to a study published online May 2 i…
Learn MoreHIV Status Does Not Affect Outcomes of Tecovirimat Treatment for Mpox
MONDAY, May 1, 2023 (HealthDay News) — HIV status seems not to affect treatment outcomes among patients receiving tecovirimat for mpox, according to a study published online May 2 in the Annals of Internal Medicine.Jacob McLean, D.O., from the Columb…
Learn MoreNew COVID-19 Drug Guards Against All Variants in Immunocompromised
FRIDAY, April 28, 2023 (HealthDay News) — A new antibody drug to help fight COVID-19 infection in immunocompromised people may be available by the end of the year.AstraZeneca said Thursday that its treatment, called AZD3152, appears to work in all va…
Learn MoreUn medicamento inyectado para la diabetes también hace perder mucho peso, encuentra un estudio
JUEVES, 27 de abril de 2023 (HealthDay News) — Mientras más estadounidenses intentan obtener el medicamento recetado Wegovy en su batalla para perder una cantidad significativa de peso, un medicamento incluso más potente contra la obesidad está a pun…
Learn MoreMost Children With ADHD Are Not Receiving Medications
FRIDAY, April 28, 2023 (HealthDay News) — Most children with parent-reported attention-deficit/hyperactivity disorder (ADHD) are not receiving medications and have never received outpatient mental health care, according to a study published online Ap…
Learn MoreSuvorexant Cuts Tau Phosphorylation and Amyloid-β Concentrations
FRIDAY, April 28, 2023 (HealthDay News) — The insomnia drug suvorexant acutely decreases tau phosphorylation and amyloid-β concentrations in the central nervous system, according to a study published online April 20 in the Annals of Neurology.Brendan…
Learn MorePrescriptions for Chronic Conditions Underused in U.S. Jails, Prisons
FRIDAY, April 28, 2023 (HealthDay News) — Prescription medications for chronic conditions are substantially underused in U.S. jails and state prisons, according to a study published online April 14 in JAMA Health Forum.Jill Curran, from Johns Hopkins…
Learn More